Skip to main content
. 2017 Jun 26;24(4):677–683. doi: 10.1177/1076029617713872

Table 2.

Results of Clot Formation Analyses of Blood Samples From Cardiac and Scoliosis Surgery Patients.a

Sample Cardiac Surgery Patients (n = 9) Scoliosis Surgery Patients (n = 10)
EXTEM Clotting Time (s) EXTEM Maximum Clot Firmness (mm) FIBTEM Maximum Clot Firmness (mm) EXTEM Clotting Time (s) EXTEM Maximum Clot Firmness (mm) FIBTEM Maximum Clot Firmness (mm)
Baseline 78 (69-88) 55 (52-58) 12 (9.2-15) 69 (61-78) 55 (51-58) 8.4 (6.6-10)
FXIII low 76 (67-85) 56 (53-58) 14 (11-16) 63 (58-69) 55 (52-58) 8.5 (6.8-10)
FXIII medium 73 (66-81) 56 (53-58) 14 (12-16) 64 (56-71) 55 (52-58) 8.9 (7.5-10)
FXIII high 70 (62-78) 57 (54-60) 15 (12-17) 62 (55-69) 55 (52-58) 9.6 (7.9-11)
FXIII low + fibrinogen 68 (60-77) 62 (60-64) 25 (24-27) 53 (47-58) 62 (59-64) 19 (17-21)
FXIII medium + fibrinogen 68 (60-76) 61 (59-64) 26 (24-28) 52 (47-56) 62 (59-65) 20 (18-22)
FXIII high + fibrinogen 67 (61-73) 63 (61-65) 28 (26-30) 54 (49-58) 62 (59-65) 21 (19-24)
FXIII low + platelets 66 (59-73) 63 (60-65) 14 (12-16) 58 (52-64) 61 (58-64) 10 (8.5-12)
FXIII medium + platelets 62 (55-70) 63 (61-65) 15 (13-17) 57 (51-62) 61 (58-64) 11 (8.8-13)
FXIII high + platelets 64 (55-73) 63 (61-65) 15 (13-18) 56 (50-61) 61 (59-64) 11 (9.0-13)

aThe blood samples were either supplemented with factor XIII (FXIII; +20%, +40%, and +60%), alone or in combination with a fixed dose of fibrinogen or platelets. Values are presented as mean and 95% confidence interval.